IMR Press / EJGO / Volume 29 / Issue 6 / pii/1631005519759-1755605252

European Journal of Gynaecological Oncology (EJGO) is published by IMR Press from Volume 40 Issue 1 (2019). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with S.O.G.

Distinguished Expert Series
Sentinel node biopsy for ipsilateral breast cancer recurrence: a review
Show Less
1 Department of Obstetrics and Gynecology, Antwerp University Hospital UZA, Edegem (Belgium)s
Eur. J. Gynaecol. Oncol. 2008, 29(6), 565–567;
Published: 10 December 2008
Abstract

The aim of this study was to review published reports on the feasability, results, and reliability of sentinel node biopsy in cases of ipsilateral recurrent breast cancer. A Medline search on publications from January 1999 to December 2007 and cross-references in published articles were looked for. We identified 16 reports on sentinel node biopsy in recurrent breast cancer, including a total of 287 patients. In 210/287 (73.2%) a sentinel node was identified, 77/210 (37.7%) had had previous axillary lymph node dissection and 131 (62.3%) a previous sentinel node procedure. Aberrant lymphatic drainage, other than the ipsilateral axilla was noted in 68/210 (32.4%). Of these 16/68 (23.6%) were located in the contralateral axilla. Of the removed contralateral axillary sentinel nodes 8/17 (47.1%) were invaded by cancer. We conclude that sentinel node biopsy in cases of recurrent ipsilateral breast cancer is feasible. In about one out of three cases drainage to the contralateral axilla with invasion in almost half the cases takes place. The therapeutical consequences of these findings need further study.
Keywords
Sentinel node
Breast cancer
Recurrent
Lymphatic drainage
Share
Back to top